GALVUS 50 MG 15 Tablets

Galvus 50 mg

Galvus 50 mg belongs to a class of anti-diabetic drugs known as dipeptidyl peptidase 4 (DPP-4) inhibitors. It is used to treat type 2 diabetes, particularly in patients whose blood sugar levels cannot be maintained through diet and exercise alone. Galvus 50 mg is a prescription medication that can be taken alone or with other medications. Type 2 diabetes is a chronic disease that impairs the glucose metabolism of the body. Individuals with type 2 diabetes either produce insufficient insulin or insulin cannot perform its function in the body (insulin resistance). The risk of developing type 2 diabetes, also known as adult-onset diabetes, increases with age.

Galvus 50 mg contains Vildagliptin, a chemical messenger known as a “incretin” hormone that functions by inhibiting its breakdown. This hormone is secreted after a meal to stimulate insulin production by the pancreas. Galvus 50 mg increases the level of the hormone ‘incretin,’ allowing the pancreas to produce sufficient insulin to reduce elevated blood sugar levels. Consequently, Galvus 50 mg contributes to the management of type 2 diabetes mellitus.

Galvus 50 mg should be taken with or without food, according to your doctor’s instructions, and should be swallowed whole with a full glass of water. Avoid crushing, chewing, and shattering. Your doctor will determine how often you should take 50 mg of Galvus based on your medical condition. In certain circumstances, you may experience vertigo, nausea, headache, excessive perspiration, hypoglycemia, and tremors. The majority of these side effects from Galvus 50 mg are mild and resolve on their own. However, if any of the adverse effects listed above persist or worsen, please consult your doctor.

Inform your physician if you are allergic to Galvus 50 mg or any other drugs. Galvus 50 mg is contraindicated in patients younger than 18 years old. Before taking Galvus 50 mg, please contact your doctor if you are pregnant, nursing, or on dialysis. Alcohol consumption should be avoided while taking Galvus 50 mg, as it may increase or decrease blood sugar levels. Galvus 50 mg is contraindicated in patients with diabetic ketoacidosis or diabetes type 1. Before taking Galvus 50 mg, inform your doctor if you have type 1 diabetes, diabetic ketoacidosis (excessive blood acids called ketones), pancreas, kidney, liver, or heart disease.

Galvus 50 mg side effects Type 2 diabetic mellitus

Medicinal Advantages

Galvus 50 mg contains Vildagliptin, an anti-diabetic medication used to treat type 2 diabetes, especially in patients for whom diet and exercise alone are insufficient to control blood sugar. Galvus 50 mg inhibits the breakdown of incretin hormones, such as glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic peptide, that regulate blood sugar levels (GIP). Consequently, the levels of these two hormones released after a meal are increased. Galvus 50 mg stimulates insulin production and inhibits glucagon production in the liver. Consequently, it aids in the regulation of blood sugar levels and the prevention of future diabetes-related complications. In addition to taking 50 mg of Galvus, a healthy diet and regular exercise will yield the best results.

Use Instructions

Galvus 50 mg should be administered precisely as prescribed by a physician. Take 50 mg of Galvus daily, with or without food, with a full glass of water. Attempt to avoid crushing or breaking it. Follow the diet prescribed by a physician.

Storage Avoid direct sunlight and store in a cool, dry area.

Galvus 50 mg Adverse Reactions

As with many other medications, Galvus 50 mg may cause side effects such as vertigo, nausea, headache, excessive perspiration, low blood sugar, and shaking. The majority of side effects associated with Galvus 50 mg are mild and resolve on their own. However, if side effects persist, you should consult your doctor.

Adverse Drug Reactions

If you are allergic to Vidagliptin or any other medication, please inform your doctor. Vidagliptin is not recommended for children younger than 18 years old. Before using Vidagliptin, please contact your doctor if you are pregnant, breastfeeding, or on dialysis. Avoid consuming alcohol while taking Vidagliptin, as it may increase or decrease blood glucose levels. In patients with diabetic ketoacidosis or type 1 diabetes, vidagliptin is contraindicated. When taking Vidagliptin, consume small, regular meals and avoid fasting for extended periods of time. Symptoms of hypoglycemia include perspiration, disorientation, palpitations, shivering, excessive thirst, dry mouth, dry skin, and frequent urination. If you experience any of these symptoms, immediately consume 5 to 6 candies, 3 glucose biscuits, or 3 teaspoons of honey/sugar and seek medical attention. Carry these at all times, particularly on extended journeys. Inform your physician if you suffer from type 1 diabetes, diabetic ketoacidosis (high levels of blood acids known as ketones), pancreatic, kidney, liver, or heart disease.

Interactions Between Drugs

Antipsychotic medications (aripiprazole, clozapine), corticosteroids (dexamethasone, prednisolone), glaucoma medications (acetazolamide), cardiac stimulants (dopamine), and thyroid medications (levothyroxine) may interact with vidagliptin (bendroflumethiazide).

Alcohol may interact with vidagliptin. Therefore, alcohol consumption should be avoided while taking Vidagliptin, as it may cause abnormally high or low blood sugar levels.

Before using Vidagliptin, you should inform your doctor if you have type 1 diabetes, diabetic ketoacidosis (excessive blood acids called ketones), pancreas, kidney, liver, or heart disease.

Safety Recommendations

ALCOHOL

It is advised to avoid consuming alcohol while taking Vidagliptin, as it may cause abnormally high or low blood sugar levels.

PREGNANCY

Vidagliptin is a pregnancy Category B medication that is typically not recommended for women who are pregnant. However, pregnant women should consult a physician before taking Vidagliptin.

BREAST FEEDING

VVidagliptin is not excreted in breast milk; therefore, it is not recommended for nursing mothers. If you are a nursing mother, please consult your physician before using Vidagliptin.

DRIVER

Vidagliptin may cause vertigo in some individuals. Therefore, avoid driving if you experience dizziness after taking Vidagliptin.

LIVER

Vidagliptin should be used with caution, especially if a family history of liver diseases or conditions exists. Your physician may adjust the dosage as needed.

KIDNEY

Vidagliptin should be used with caution, especially if a history of kidney disease/conditions runs in your family. Your physician may adjust the dosage as needed.

No.

Advice on Diet and Lifestyle

At least 30 minutes per day should be devoted to regular exercise, such as cycling, walking, jogging, dancing, or swimming. Exercise for at least 150 minutes per week.

Maintain a healthy weight, as obesity is also linked to the onset of diabetes.

Consume a diet low in fat and sugar. Substitute whole grains, fruits, and vegetables for foods containing carbohydrates, as the conversion of carbohydrates to sugars results in elevated blood sugar levels.

Avoid consuming alcohol and tobacco.

Special Guidance

Prior to initiating Vidagliptin medication, liver function tests are recommended every three months for the first year, and thereafter on a regular basis to monitor for evidence of elevated liver enzymes.

In addition, this item cannot be returned

Concern for Patients

Type 2 diabetes is a chronic (long-lasting) disease in which the body cannot utilize insulin effectively. Consequently, individuals with type 2 diabetes either do not produce enough insulin or are resistant to insulin. Adults of middle age or older are more likely to develop type 2 diabetes, also known as adult-onset diabetes. Type 2 diabetes is characterized by an increase in thirst, nighttime urination, poor wound healing, an increase in appetite, fatigue, and blurred vision. In rare instances, weight loss may occur, whereas weight gain is possible under certain conditions. Complications of type 2 diabetes include nerve damage, renal problems, retinal damage or blindness, amputation of limbs, sexual dysfunction, and an increased risk of heart attack or stroke.

FAQs

Vildagliptin, the active ingredient in Galvus 50 mg, is an anti-diabetic medication that regulates blood sugar by inhibiting the breakdown of incretin hormones, such as glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic peptide (GIP). Consequently, the levels of these two hormones rise. Vidagliptin stimulates insulin production in the pancreas and inhibits glucagon synthesis in the liver. Consequently, it contributes to the regulation of blood sugar levels.

Vidagliptin is compatible with metformin. Consult your doctor before combining Vidagliptin with other medications to ensure that the dose is adjusted appropriately.

Vidagliptin should be administered with extreme caution to patients who have or have had pancreatitis (pancreas edema), as it may increase the risk of pancreatitis recurrence or exacerbate the condition. However, if you experience symptoms such as nausea, vomiting, or abdominal pain, consult a doctor immediately.

Vidagliptin does not independently cause hypoglycemia. However, low blood sugar levels may occur when Vidagliptin is combined with other anti-diabetic drugs, when alcohol is consumed, when normal levels of exercise are exceeded, or when snacks or meals are delayed or missed. Nevertheless, if you experience low blood pressure symptoms such as dizziness, nausea, lightheadedness, dehydration, or fainting, you should consult a doctor.

No, it is not recommended that you stop taking Vidagliptin on your own, as doing so may result in recurrent symptoms or worsen your condition. Please inform your doctor if you experience any side effects while taking Vidagliptin so that an alternative medication can be prescribed.

Skin lesions caused by diabetes are a typical complication of the disease. It is essential, however, that you adhere to your doctor’s foot and skin care instructions, and that you see a doctor if you develop new ulcers or blisters while taking Vidagliptin.